Published by Iain Gilbert on 31st March 2021
(Sharecast News) - Analysts at Jefferies upgraded drugmaker Hikma Pharmaceuticals from 'hold' to 'buy' on Wednesday, stating the group's share price was yet to reflect "a series of upcoming product catalysts".
URL: http://www.digitallook.com/dl/news/story/31745502/...